Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind trial evaluating immunogenicity and safety of MVA-BN (IMVAMUNE) smallpox vaccine in healthy subjects; results posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• MVA-BN (IMVAMUNE) (Modified Vaccinia Ankara-Bavarian Nordic vaccine (IMVAMUNE))

Snippet

Sponsor: Bavarian Nordic | Conditions: Smallpox | Phase 2 | Status: COMPLETED | Results posted: 2019-01-09